The Affordable Medicines Facility-malaria (AMFm) is an innovative financing mechanism, managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, to increase the use of artemisinin-based combination therapies for treating malaria. To evaluate the AMFm pilot in eight countries, E2Pi conducted an analysis estimating predetermined “benchmarks” of success at 1 and 2 years.

The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health. 

The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health. 

The Evidence to Policy Initiative (E2Pi) is a global health policy collaboration between UCSF Global Health Group and SEEK Development. E2Pi conducts independent analysis and evidence synthesis to inform discussion and decision-making on critical policy and strategic issues in global health. 

The GAVI Alliance, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank are developing a Health Systems Funding Platform to coordinate aid to health systems. E2Pi’s Policy Brief discusses the Platform’s objectives and operational framework, the current status of its implementation, and the challenges it faces.